Research Topics
Species | S J WhittakerSummaryAffiliation: King's College London Country: UK Publications
| Collaborators
|
Detail Information
Publications
Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL)Sean Whittaker
St Johns Institute of Dermatology, Guys and St Thomas Hospital, London, UK
Semin Oncol 33:S3-6. 2006..This article reviews our current understanding of the pathogenetic abnormalities involving genomic mutations, abnormal cDNA expression, and dysregulation of signaling pathways in CTCL...
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphomaSean J Whittaker
Guy s and St Thomas National Health Service Foundation Trust, London, United Kingdom
J Clin Oncol 28:4485-91. 2010..The primary objective of this study was to confirm the efficacy of romidepsin in patients with treatment refractory cutaneous T-cell lymphoma (CTCL)...
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomasS J Whittaker
St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K
Br J Dermatol 149:1095-1107. 2003
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphomaSean J Whittaker
St John s Institute of Dermatology, Guys and St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
Cancer Treat Rev 33:146-60. 2007....
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoidesE A Fraser-Andrews
Department of Dermatopathology, St John s Institute of Dermatology, St Thomas Hospital, London SE1 7EH, UK
Br J Dermatol 155:756-62. 2006..Histological evidence of lymph node involvement is associated with a poor prognosis in patients with cutaneous T-cell lymphoma (CTCL)...
Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphomaF J Child
Skin Tumour Unit and Department of Dermatopathology, St John s Institute of Dermatology, St Thomas Hospital, London SE1 7EH, UK
Br J Dermatol 144:735-44. 2001..Bcl-2 protein prevents apoptosis and the translocation leads to overexpression of a functionally normal Bcl-2 protein that prevents apoptosis of neoplastic cells...
Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoidesE A Fraser-Andrews
Skin Tumour Unit, St John s Institute of Dermatology, United Medical and Dental School of Guy s and St Thomas s Hospital, London, UK
J Invest Dermatol 114:117-21. 2000..Keywords: polymerase chain reaction/single-strand conformational polymorphism/T cell receptor gene rearrangement. J Invest Dermatol 114:117-121, 2000..
Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTENJ J Scarisbrick
Skin Tumour Unit, St John s Institute Dermatology, St Thomas Hospital, London, United Kingdom
Blood 95:2937-42. 2000..Furthermore, abnormalities of PTEN may be important in the pathogenesis of mycosis fungoides, but our data imply that this gene is rarely inactivated by small deletions or point mutations. (Blood. 2000;95:2937-2942)..
Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17pJ J Scarisbrick
Skin Tumour Unit, St John s Institute Dermatology, St Thomas Hospital, London, UK
J Invest Dermatol 117:663-70. 2001..These results provide the basis for further studies defining more accurately chromosomal regions of deletions and candidate tumor suppressor genes involved in mycosis fungoides and Sézary syndrome...
A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoidesF J Child
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, London, UK
Clin Exp Dermatol 29:231-6. 2004..Although PUVA was more effective than ECP, neither treatment modality cleared malignant T-cells from the peripheral blood...
A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphomaJ J Scarisbrick
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, U K
Br J Dermatol 144:1010-5. 2001..The combination of fludarabine and cyclophosphamide shows synergistic toxicity in vitro and has been used to treat nodal non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukaemia...
Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndromeE A Fraser-Andrews
Skin Tumor Unit, St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom
Cancer 92:1745-52. 2001..Sézary syndrome (SS) is characterized by erythroderma, peripheral lymphadenopathy, and circulating Sézary cells and is clinically heterogeneous...
BCL2 and JUNB abnormalities in primary cutaneous lymphomasX Mao
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, London SE1 7EH, UK
Br J Dermatol 151:546-56. 2004..BCL2 is upregulated in nodal and extranodal B-cell non-Hodgkin's lymphomas, with a consequent antiapoptotic effect. However, loss of BCL2 has also been noted in some malignancies, suggesting a different molecular pathogenesis...
Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphomaF J Child
Skin Tumor Unit, St John s Institute of Dermatology, St Thomas Hospital, London, UK
J Invest Dermatol 117:984-9. 2001..Our data indicate that the FR3 consensus primer alone is not sufficient for a comprehensive analysis of primary cutaneous B cell lymphoma...
Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of responseA V Evans
Skin Tumour Unit, St John's Institute of Dermatology, St Thomas' Hospital, London, United Kingdom
Blood 98:1298-301. 2001..Alternatively, minimum tumor burden might be required for the induction of a cytotoxic response. Analysis of tumor-specific cytotoxic T cells is needed to investigate these possibilities further...
Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patientsS R Hoque
Department of Dermatopathology, St John s Institute of Dermatology, St Thomas Hospital, London, UK
Br J Dermatol 148:516-25. 2003..In the World Health Organization classification of T-cell and natural killer cell lymphoma it is listed as an example of extranodal lymphoma. In practice, however, it is most likely to present to a dermatologist...
Bexarotene therapy for mycosis fungoides and Sézary syndromeR A Abbott
St John s Institute of Dermatology, St Thomas Hospital, London, UK
Br J Dermatol 160:1299-307. 2009..Bexarotene (Targretin) is a synthetic retinoid which is licensed for the treatment of advanced refractory cutaneous T-cell lymphoma (CTCL)...
T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvementE Olavarria
Department of Haematology, Hammersmith Hospital, ICSM, London, UK
Br J Haematol 114:624-31. 2001..Despite a short relapse-free survival, most patients achieved good disease control at the time of relapse...
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosisB Delage
Barts Cancer Institute, Queen Mary University of London, Centre for Molecular Oncology, London, UK
Cell Death Dis 3:e342. 2012..In summary, ASS1 promoter methylation contributes to arginine auxotrophy and represents a novel biomarker for evaluating the efficacy of arginine deprivation in patients with lymphoma...
Sézary syndrome with a complex, frameshift p53 gene mutation in a Chernobyl survivorE A Fraser-Andrews
Skin Tumour Unit, Department of Photobiology, St John s Institute of Dermatology, St Thomas Hospital, London, UK
Clin Exp Dermatol 26:683-5. 2001..This is characteristic of damage caused by ionizing radiation, which suggests a causal link between exposure to ionizing radiation and the subsequent development of Sézary syndrome, a rare form of T-cell leukaemia/lymphoma...
Can we safely diagnose pigmented lesions from stored video images? A diagnostic comparison between clinical examination and stored video images of pigmented lesions removed for histologyV M Jolliffe
Department of Dermatology, The Royal Free Hospital, London, UK
Clin Exp Dermatol 26:84-7. 2001..Further evaluation of the cost : benefit ratio of such a system to the health care provider must be undertaken before considering this technique as a potential adjunct to managing outpatient referrals...
Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1R C T McKenzie
Skin Tumour Unit, St John s Institute of Dermatology, Division of Genetics and Molecular Medicine, King s College London, London, UK
Leukemia 26:323-31. 2012..These data demonstrate that constitutive activation of STAT3 in SS is not due to the loss of SHP-1, but is mediated by constitutive aberrant activation of JAK family members...
Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UKF J Child
Department of Dermatopathology, St John s Institute of Dermatology, St Thomas Hospital, London, UK
Br J Dermatol 148:507-15. 2003..The new World Health Organization classification of lymphoma/leukaemia recognizes several types of NK/T-cell neoplasm, including blastic NK-cell lymphoma, which characteristically presents with cutaneous lesions...
Granulomatous mycosis fungoides presenting as an acquired ichthyosisS Eisman
Department of Dermatology, Royal Free Hospital, London, UK
Clin Exp Dermatol 28:174-6. 2003..Skin histology, immunophenotyping and molecular features were consistent with granulomatous mycosis fungoides. He has been successfully treated with twice weekly PUVA photochemotherapy...
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoidesX Mao
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, U K
Br J Dermatol 147:464-75. 2002..Data on genome-wide surveys for chromosome aberrations in primary cutaneous T-cell lymphoma (CTCL) are limited...
Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case reportN Agar
St John s Institute of Dermatology, St Thomas Hospital, Lambeth Palace Rd SE1 7EH, London, U K
Br J Dermatol 159:1197-9. 2008..We present the first report detailing the stepwise progression of a patient with stage IIA folliculotropic MF to SS. This case demonstrates that MF and SS represent a clinical spectrum of the same disease...
Cutaneous Waldenström's macroglobulinaemiaI Chan
St John s Institute of Dermatology, St Thomas Hospital, London
Clin Exp Dermatol 28:491-2. 2003..Direct cutaneous infiltration by neoplastic lymphoid cells is less common, and very rare as the initial presentation of Waldenström's macroglobulinaemia...
Can we use video images to triage pigmented lesions?V M Jolliffe
Department of Dermatology, Royal Free Hospital, London, UK
Br J Dermatol 145:904-10. 2001..Advances in telemedicine permit consultations where the doctor and patient are at different sites...
Molecular analysis of T-cell receptor beta genes in cutaneous T-cell lymphoma reveals Jbeta1 biasSuzanne M Morgan
Molecular Pathology, Cancer Sciences Division, School of Medicine, General Hospital, Southampton University Hospitals NHS Trust, Southampton, UK
J Invest Dermatol 126:1893-9. 2006..Although we found that TCRB gene usage in CTCL and normal individuals share common features, our analysis also revealed preferential usage of Jbeta1 genes in all cases with advanced stages of disease...
Fine mapping of chromosome 10q deletions in mycosis fungoides and sezary syndrome: identification of two discrete regions of deletion at 10q23.33-24.1 and 10q24.33-25.1E Mary Wain
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, London, UK
Genes Chromosomes Cancer 42:184-92. 2005..1, around microsatellite marker D10S530 (3.92 Mb), encodes 11 genes, the majority of which have poorly identified functions. This extensive allelotyping study provides the basis for future highly selective candidate gene analyses...
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomasXin Mao
Skin Tumour Unit and Dermatopathology Department, St John s Institute of Dermatology, St Thomas Hospital, London, United Kingdom
Blood 101:1513-9. 2003..These results have revealed, for the first time, amplification and expression patterns of JUNB in PCL, suggesting that JUNB may be critical in the pathogenesis of primary cutaneous T-cell lymphomas...
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesisXin Mao
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, King s College, London, UK
J Invest Dermatol 126:1388-95. 2006..These findings suggest heterogeneous abnormalities of CCND and RB in CTCL, in which dysregulated CCND and RB1 may lead to impaired cell cycle control...
Cutaneous malignant melanoma in association with mycosis fungoidesAlun V Evans
Skin Tumour Unit, St John s Institute of Dermatology, London, United Kingdom
J Am Acad Dermatol 50:701-5. 2004..The reason for this association is unclear, but this report emphasizes the risk of second malignancies for patients with cutaneous T-cell lymphoma and melanoma...
Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndromeJulia J Scarisbrick
Skin Tumor Unit, St John s Institute Dermatology, St Thomas Hospital, Lambeth Palace Road, London, UK
J Invest Dermatol 118:493-9. 2002....
Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular studyE Mary Wain
Skin Tumour Unit, St John s Institute of Dermatology, St Thomas Hospital, London, United Kingdom
Cancer 98:2282-90. 2003..The aims of the current study were to describe the clinical presentation, pathologic features, and disease progression (DP) in patients who developed MF before age 16 years...
Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoidesJulia J Scarisbrick
Skin Tumour Unit, St John s Institute Dermatology, St Thomas Hospital, London, UK
J Invest Dermatol 121:894-901. 2003..This suggests that the development of a mutator phenotype may contribute to disease progression in mycosis fungoides...
Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary SyndromeTracey J Mitchell
Skin Cancer Unit, St. Johns Institute of Dermatology, Division of Skin Sciences, Kings College London, St. Thomas Hospital, London, United Kingdom
Cancer Res 63:9048-54. 2003..Thus, aberrant expression of Stat5(t) may be one mechanism that contributes to the cellular transformation of T cells in this disease...
Histopathology and genetics of cutaneous T-cell lymphomaBruce R Smoller
Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, USA
Hematol Oncol Clin North Am 17:1277-311. 2003..It is hoped that greater understanding of these molecular abnormalities will permit the development of CTCL-specific therapies that alleviate suffering and prolong survival...
Multiple familial pilomatricomas: an unusual caseVirginia G Hubbard
Department of Dermatology, Bart s Hospital, London, UK
J Cutan Pathol 31:281-3. 2004..We describe a 29-year-old man with multiple pilomatricomas whose father and brother also had similar lesions. There is no history of myotonic dystrophy...
Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphomaMachteld M Tiemessen
Immunobiology Department, Division of Immunology, Infection and Inflammatory Disease, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals, London, UK
J Invest Dermatol 126:2217-23. 2006..Our findings thus indicate a dysfunction of peripheral Tregs in certain CTCL patients, which correlates with tumor burden...
CD30(+) cutaneous lymphoma in association with atopic eczemaClair L Fletcher
Department of Dermatopathology, St John's Institute of Dermatology, St Thomas' Hospital, London, England
Arch Dermatol 140:449-54. 2004..Biopsies of lesional skin from subjects with atopic eczema exhibit a proportion of CD30 cells, and clonal transformation of this subpopulation might account for the CD30(+) lymphomas in our patients...
Palliative care in patients with primary cutaneous lymphoma: symptom burden and characteristics of hospital palliative care team inputBeata Lebon
Arch Dermatol 143:423-4. 2007
